Pulse Biosciences, Inc.
NASDAQ:PLSE
18.73 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -42.21 | -58.505 | -63.66 | -49.851 | -46.971 | -37.545 | -25.567 | -9.518 | -2.811 | -0.475 |
| Depreciation & Amortization
| 1.207 | 1.355 | 1.146 | 1.095 | 1.16 | 1.31 | 1.001 | 0.759 | 0.717 | 0.201 |
| Deferred Income Tax
| -0.263 | 0 | 0 | 0 | 0 | 0.028 | 0.026 | -0.87 | -1.657 | 0 |
| Stock Based Compensation
| 7.181 | 5.191 | 14.601 | 10.075 | 11.287 | 12.338 | 10.926 | 0.87 | 0.402 | 0 |
| Change In Working Capital
| 0.768 | -3.716 | -6.197 | 3.2 | 0.86 | 0.113 | 0.408 | -0.166 | -1.625 | 0.12 |
| Accounts Receivables
| 0.109 | 0.061 | -0.061 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | -2.653 | -5.824 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0.263 | -1.304 | 1.16 | -0.266 | 0.646 | 0.49 | 0.517 | 0.003 | 0.125 | 0 |
| Other Working Capital
| 0.396 | 0.18 | -1.472 | 3.466 | 0.214 | -0.377 | -0.109 | -0.169 | -1.749 | 0.12 |
| Other Non Cash Items
| 0.276 | 8.662 | 0.013 | 0.116 | -0.521 | -0.112 | 2.119 | 0.874 | 1.657 | -0.019 |
| Operating Cash Flow
| -33.041 | -47.013 | -54.097 | -35.365 | -34.185 | -23.896 | -11.087 | -8.051 | -3.317 | -0.173 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -0.121 | -0.401 | -0.437 | -0.441 | -0.608 | -0.276 | -2.551 | -0.064 | -0.086 | -0.079 |
| Acquisitions Net
| 0 | 0 | 0 | -10.485 | 9.493 | 0 | 0 | 0.064 | 0 | 0.002 |
| Purchases Of Investments
| 0 | 0 | 0 | -29.025 | -77.993 | -40.297 | -43.595 | -19.067 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 8 | 39.51 | 68.5 | 66.69 | 23.148 | 4.75 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 8 | 10.485 | -9.493 | 26.393 | -20.447 | -0.064 | 0 | 0 |
| Investing Cash Flow
| -0.121 | -0.401 | 7.563 | 10.044 | -10.101 | 26.117 | -22.998 | -14.381 | -0.086 | -0.077 |
| Financing Activities: | ||||||||||
| Debt Repayment
| 0 | -64.563 | -1.532 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 16.394 | 15.376 | 56.697 | 30.885 | 0.695 | 45.611 | 35.382 | 20.915 | 0 | 0 |
| Common Stock Repurchased
| 0.395 | 0.486 | 0.81 | 0.49 | -0.613 | -0.115 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.006 | -0.437 | 7.52 | 30.885 | 0.695 | 45.611 | 35.382 | 20.915 | 0 | 12.266 |
| Financing Cash Flow
| 16.388 | 79.939 | 62.685 | 30.885 | 0.082 | 45.496 | 35.382 | 20.915 | 0 | 12.266 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -16.774 | 32.525 | 16.151 | 5.564 | -44.204 | 47.717 | 1.297 | -1.517 | -3.403 | 12.015 |
| Cash At End Of Period
| 44.365 | 61.139 | 28.614 | 12.463 | 6.899 | 51.103 | 3.386 | 2.089 | 3.606 | 12.015 |